Mould Exposure Assessment - MycoTOX Profile

Mycotoxins are secondary metabolites produced by certain mould species. Growing research has highlighted their potential impact on human health, particularly in individuals with prolonged exposure to water-damaged environments or contaminated food sources.

Because symptoms can be varied and non-specific, mycotoxin exposure may be difficult to identify without appropriate laboratory assessment.

The MycoTOX Profile uses LC-MS/MS (Liquid Chromatography–Tandem Mass Spectrometry), a highly sensitive and validated analytical method.

This approach measures mycotoxin metabolites excreted in urine, providing insight into recent or ongoing internal exposure.

While no single test provides a complete picture of environmental exposure, urine LC-MS/MS is widely used in research and clinical settings for quantitative mycotoxin assessment.

Testing may be considered in individuals with:

• Suspected exposure to water-damaged buildings
• Persistent fatigue
• Cognitive or concentration difficulties
• Mood changes
• Immune dysregulation
• Respiratory concerns
• Chronic inflammatory patterns
• Multi-system presentations without clear explanation

Mycotoxin testing does not diagnose specific diseases.

Research has explored associations between mould exposure and various neurological, respiratory, inflammatory, and immune-related conditions. However, test results must be interpreted alongside:

• Exposure history
• Environmental assessment
• Clinical presentation
• Other pathology findings

Elevated results indicate measurable exposure and may guide further environmental investigation and structured support strategies where appropriate.